相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
Daniel Thomas et al.
CANCER DISCOVERY (2023)
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
Mahmoud A. Bassal et al.
NATURE COMMUNICATIONS (2022)
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
Bachar Samra et al.
FRONTIERS IN ONCOLOGY (2020)
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data
Subarna Sinha et al.
NATURE COMMUNICATIONS (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
IDH mutations in liver cell plasticity and biliary cancer
Supriya K. Saha et al.
CELL CYCLE (2014)
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Franziska Baenke et al.
DISEASE MODELS & MECHANISMS (2013)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
IDH mutations in glioma and acute myeloid leukemia
Lenny Dang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
分享论文
